openPR Logo
Press release

Global Gastric Cancer Drugs Market Report 2024: Market Segments, Size, Trend and Market Projections for Upcoming Years

05-10-2018 11:06 AM CET | Health & Medicine

Press release from: Infinium Global Research

Infinium Global Research

Infinium Global Research

Gastric Cancer Drugs Market report provides the latest market data along with industry future trends, which keeps tracking of users driving revenue growth rate of Gastric Cancer Drugs Market by route of administration (oral and parenteral), by lines of chemotherapy (first-line chemotherapy and second-line chemotherapy), by molecule type (small molecules and biologics) market status and outlook of global and major regions, from manufacturers, and end industries. As this report is expected to help key players among the Gastric Cancer Drugs Market it includes the five years Industry analysis and the 6 years annual forecast from 2018 to 2024. According to report the global gastric cancer drugs market is projected to grow at a CAGR of 9.5% over the forecast period of 2018-2024.

Purchase Global Gastric Cancer Drugs market by route of administration (oral and parenteral), by lines of chemotherapy (first-line chemotherapy and second-line chemotherapy), by molecule type (small molecules and biologics) and by region (North America, Europe, Asia Pacific, Latin America and RoW) report on https://www.infiniumglobalresearch.com/healthcare_medical_devices/global_gastric_cancer_drugs_market

The report also identifies the drivers and restraints that affect the gastric cancer drugs market over the period of 2018 to 2024.

Rising Acceptability of Gastric Cancer Drugs

Rising acceptability of gastric cancer drugs due to increasing public awareness regarding the treatment of gastric cancer is the latest trend in the global gastric cancer drugs market. Moreover, various awareness organizations spreading awareness regarding the disease through various social media platforms and blogs will further surge this trend over the forecast period.

Growing Incidence of Gastric Cancer and High Unmet Needs

Growing incidences of gastric cancer and high unmet needs in the market results in rising R&D are the key factors responsible for the growth of global gastric cancer drugs market. Moreover, changing lifestyle habits such as smoking, intake of alcohol and rising obesity are responsible for the growing incidence of gastric cancer. Furthermore, due to high unmet needs in the market results in introduction of safe and effective novel therapies for the gastric cancer.

North America Region is the Largest Consumer among the Geographies Followed by Europe While APAC to Grow at a Highest CAGR

The global Gastric Cancer Drugs market has been dominated by the Asia Pacific region over the historic period 2015-16 followed by Latin America. Presence of countries like China and Japan dealing with large patient base and increasing demand for improved healthcare across the region is the key factor responsible for the growth of gastric cancer drugs market in the APAC region. Furthermore, the Asia-Pacific region is expected to grow at a highest CAGR over the period of 2018 to 2024. Moreover, growth in treatment seeking population in the region and rising awareness among the population are anticipated to boost the market for Gastric Cancer Drugs.

The companies covered in the report include Amgen, AROG Pharmaceuticals, Ipsen Biopharmaceuticals, Array Biopharma, Taiho Oncology, AstraZeneca, ARIAD Pharmaceuticals, Eli Lilly, Galena Biopharma and ASLAN Pharmaceuticals.

Browse Detailed TOC, Description and Companies Mentioned in Report @ https://www.infiniumglobalresearch.com/healthcare_medical_devices/global_gastric_cancer_drugs_market

Table of Contents

1. Preface
1.1.         Report Description
1.2.         Research Methods
1.3.         Research Approaches

2. Executive Summary

3. Global Gastric Cancer Drugs Market Overview
3.1.         Introduction
3.2.         Market Dynamics
3.2.1.     Drivers
3.2.2.     Restraints
3.2.3.     Opportunities
3.3.         Porter's Five Forces Analysis
3.4.         IGR-Growth Matrix Analysis
3.5.         Competitive Landscape in the Global Gastric Cancer Drugs Market

4. Global Gastric Cancer Drugs Market by Route of Administration
4.1.         Oral
4.2.         Parenteral

5. Global Gastric Cancer Drugs Market by Lines of Chemotherapy
5.1.         First-Line Chemotherapy
5.2.         Second-Line Chemotherapy

6. Global Gastric Cancer Drugs Market by Molecule Type
6.1.         Small Molecules
6.2.         Biologics

7. Global Gastric Cancer Drugs Market by Region 2018-2024
7.1.         North America
7.1.1.     North America Gastric Cancer Drugs Market by Route of administration
7.1.2.     North America Gastric Cancer Drugs Market by Lines of Chemotherapy
7.1.3.     North America Gastric Cancer Drugs Market by Molecule Type
7.1.4.     North America Gastric Cancer Drugs Market by Country
7.2.         Europe
7.2.1.     Europe Gastric Cancer Drugs Market by Route of Administration
7.2.2.     Europe Gastric Cancer Drugs Market by Lines of Chemotherapy
7.2.3.     Europe Gastric Cancer Drugs Market by Molecule Type
7.2.4.     Europe Gastric Cancer Drugs Market by Country
7.3.         Asia-Pacific
7.3.1.     Asia-Pacific Gastric Cancer Drugs Market by Route of Administration
7.3.2.     Asia-Pacific Gastric Cancer Drugs Market by Lines of Chemotherapy
7.3.3.     Asia-Pacific Gastric Cancer Drugs Market by Molecule Type
7.3.4.     Asia-Pacific Gastric Cancer Drugs Market by Country
7.4.         RoW
7.4.1.     RoW Gastric Cancer Drugs Market by Route of Administration
7.4.2.     RoW Gastric Cancer Drugs Market by Lines of Chemotherapy
7.4.3.     RoW Gastric Cancer Drugs Market by Molecule Type
7.4.4.     RoW Gastric Cancer Drugs Market by Sub-region

8. Company Covered
8.1.         Amgen
8.2.         AROG Pharmaceuticals
8.3.         Ipsen Biopharmaceuticals
8.4.         Array Biopharma
8.5.         Taiho Oncology
8.6.         AstraZeneca
8.7.         ARIAD Pharmaceuticals
8.8.         Eli Lilly
8.9.         Galena Biopharma
8.10.      ASLAN Pharmaceuticals 

Following Important Points are covered in Gastric Cancer Drugs Market Report:

1. Comprehensive analysis of global as well as regional markets of Gastric Cancer Drugs

2. Complete coverage of all the product type and applications segments to analyze the trends, developments, and forecast of market size up to 2024.

3. Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.

4. Infinium Global Research- Growth Matrix presents analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

About Us:

Infinium Global Research and Consulting Solutions is started with a single motto of being business partner of first choice. We at Infinium work on the strengths of our clients to ensure we help them consolidate their market position. We firmly believe in the fact that ‘if you are able to develop newer opportunities then you find there is no dearth of opportunities for you. With our strategic research approaches and deep dive in the market segments, we try to find out new opportunities that our clients can encash with their existing resources. Our experts with over 100 years of cumulative experience in research offer the best in the industry services to our clients to ensure that they achieve their business goals.

Contact Us:

Infinium Global Research
Goyal Shinde Park, Bhau Patil Road,
Bopodi, Pune-411 020.
U.S. + Canada Toll Free: 1-800-638-0796
Email: sales@infiniumglobalresearch.com
Website: https://www.infiniumglobalresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Gastric Cancer Drugs Market Report 2024: Market Segments, Size, Trend and Market Projections for Upcoming Years here

News-ID: 1045715 • Views:

More Releases from Infinium Global Research

Sustainable Aviation Fuel (SAF) Market Growth Outlook Strong with USD 5000 Million Valuation by 2028
Sustainable Aviation Fuel (SAF) Market Growth Outlook Strong with USD 5000 Milli …
The global sustainable aviation fuel (SAF) market is witnessing an unprecedented surge, growing from nearly USD 290 million in 2022 to over USD 5,000 million by 2028, at a remarkable CAGR of more than 60%. This rapid expansion highlights the industry's strong commitment to decarbonizing aviation, which remains one of the most carbon-intensive transportation sectors. SAF, produced from renewable resources such as waste oils, agricultural residues, municipal waste, and biomass,
Automotive Windshield Market Size to Expand from USD 17.49 Bn in 2023 to USD 30.84 Bn in 2032
Automotive Windshield Market Size to Expand from USD 17.49 Bn in 2023 to USD 30. …
The global automotive windshield market is one of the most essential components of the automotive industry, ensuring both passenger safety and driver visibility. Valued at USD 17.49 billion in 2023, the market is projected to reach USD 30.84 billion by 2032, expanding at a CAGR of 6.53% from 2024 to 2032. Windshields are no longer just protective glass panels; they have evolved into high-performance safety components incorporating advanced technologies such
Satellite Communication Equipment Market Poised for USD 44 Bn by 2032
Satellite Communication Equipment Market Poised for USD 44 Bn by 2032
The global satellite communication (SATCOM) equipment market is undergoing rapid expansion, fueled by the increasing need for reliable connectivity across diverse applications. Valued at approximately USD 20 billion in 2023, the market is forecasted to nearly double, reaching USD 44 billion by 2032, registering a CAGR of almost 10% during 2024-2032. SATCOM equipment, comprising receivers, antennas, transponders, and transceivers, plays a critical role in enabling long-distance communication for both commercial
Solar Vehicle Market Growth Outlook Strong with USD 6.25B Valuation by 2032
Solar Vehicle Market Growth Outlook Strong with USD 6.25B Valuation by 2032
The global solar vehicle market is rapidly emerging as one of the most promising segments in sustainable mobility. Valued at USD 331.68 million in 2023, the market is expected to surge to USD 6,255.20 million by 2032, expanding at an impressive CAGR of 38.63% from 2024 to 2032. This unprecedented growth reflects the convergence of rising environmental concerns, government initiatives, and technological breakthroughs in solar panel and battery efficiency. Solar

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports. Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For